Kannaway, the direct selling subsidiary of Medical Marijuana, Inc., announced that its Japan and South Africa divisions reached their largest revenue month in company history during January 2022.
“Being able to achieve four best revenue months in a row in the Japan market has been both a great way to end 2021 and an inspiring way to start 2022,” said Medical Marijuana, Inc. CEO Blake Schroeder. “Now that we’ve reached this milestone in South Africa as well, we anticipate that both regions will be major market areas for us this year and beyond.”
Kannaway points to a projection by Business Insider Africa, that estimates the African cannabis industry will grow beyond a $7 billion valuation by 2023, as evidence that the company’s growth in the region could soon grow exponentially.
